bigram

This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

bigram	frequency
study design	532
case studies	488
background case	481
design method	387
results finding	375
united states	272
case report	264
public health	246
clinical trials	243
blood bank	193
drug administration	191
red blood	178
methods materials	168
blood donors	165
whole blood	147
results findings	144
design methods	139
member states	133
blood center	130
blood products	127
blood components	108
clinical trial	107
blood cells	106
fda approved	106
health care	103
steering committee	102
medical center	99
stem cell	98
adverse events	96
red cell	93
infectious diseases	93
blood cell	93
imaging findings	90
nucleic acid	89
gene therapy	88
blood group	87
viral load	86
us fda	85
time pcr	84
approved drugs	84
respiratory syndrome	82
pediatric patients	80
transfusion medicine	80
transfusion service	78
mg dl	78
medicinal products	76
rbc units	76
patient care	75
acute respiratory	75
blood transfusion	75
outsourcing facilities	73
bone marrow	72
blood product	72
ebola virus	70
blood donor	70
quality control	69
infectious disease	65
virus infection	62
fda labels	62
pediatric radiology	61
may also	60
immune response	59
performed using	59
blood donation	59
side effects	56
drug products	55
severe acute	55
monoclonal antibody	55
kcal mol	55
rhce ce	54
clinical studies	54
blood supply	54
antibody screen	54
transfusion reactions	54
clinically significant	53
working group	53
risk factors	53
human genome	53
donor screening	52
peripheral blood	52
stem cells	52
clinical practice	51
blood centers	51
mass spectrometry	50
platelet count	50
supply chain	50
biological products	49
drug repurposing	49
flow cytometry	49
magnetic resonance	48
assessment report	48
diagnostic tests	48
doc id	48
antibiotic resistance	48
cord uid	48
health organization	47
emergency use	47
statistically significant	47
commercially available	47
drug discovery	46
rna polymerase	46
red cells	46
medical device	46
center background	46
blood donations	46
massive transfusion	45
drug development	45
will also	45
blood safety	44
phase ii	44
ich regions	44
novel coronavirus	44
viral infections	44
zika virus	44
world health	44
phase i	44
significant difference	43
adverse effects	43
antibiotic use	43
patient safety	43
abo rh	43
radiation dose	43
heart disease	42
pathogen reduction	42
sickle cell	42
one patient	42
increased risk	41
positive samples	41
pharmaceutical companies	41
image quality	41
animal model	41
ng ml	41
clinical laboratories	41
new drug	41
red cross	40
test results	40
coronavirus disease	40
intended use	40
blood type	40
hematopoietic stem	40
transfusion services	40
european medicines	39
transplant recipients	39
immunodeficiency virus	39
least one	39
per year	39
medical record	39
retrospective review	39
antiviral drugs	39
phase iii	38
significant differences	38
rbc transfusion	38
blood services	38
computed tomography	38
pediatric population	38
significantly higher	38
cl pro	37
congenital heart	37
wide range	37
fda approval	36
viral replication	36
medical devices	36
apheresis platelets	36
mr imaging	36
adverse event	36
infection control	36
blood component	36
soft tissue	36
gene transfer	36
clinical data	36
within hours	36
patients receiving	35
pharmaceutical products	35
small molecule	35
disease control	35
important role	35
ich steering	35
antimicrobial resistance	34
white matter	34
clinical laboratory	34
marketing authorization	34
advisory committee	34
animal rule	34
syndrome coronavirus	34
clinical development	34
blood loss	34
high risk	34
health emergency	33
states food	33
will discuss	33
blood banks	33
systematic review	33
electronic medical	33
herpes simplex	33
human immunodeficiency	33
cell disease	33
immune system	33
cd cells	32
differential diagnosis	32
developing countries	32
resonance imaging	32
laboratory testing	32
imaging features	32
intensive care	32
diagnostic testing	32
clinical use	32
past years	32
member state	32
pharmaceutical regulations	32
year period	31
genetic testing	31
regulatory requirements	31
monoclonal antibodies	31
staphylococcus aureus	31
regulatory authorities	31
posterior fossa	31
spinal cord	31
fetal mri	31
patient blood	31
blood volume	31
national dras	31
animal models	30
endoscope reprocessing	30
quantitative real	30
month period	30
viral loads	30
flexible endoscopes	30
medicines agency	30
tertiary care	30
medically important	30
level disinfection	29
retrospective study	29
ich guidelines	29
lung disease	29
docking score	29
american red	29
animal health	29
adverse reactions	29
transfusion vol	29
educational content	29
commonly used	29
immune responses	29
chain reaction	29
transfusion reaction	29
viral rna	29
human services	29
bacterial contamination	28
cell lines	28
widely used	28
determine whether	28
hydrogen peroxide	28
regional blood	28
hemolytic anemia	28
blood management	28
human use	28
growth factor	28
plasma exchange	28
cell transplantation	28
prescribing information	28
significantly lower	27
european union	27
cystic fibrosis	27
middle east	27
american college	27
human health	27
international standards	27
may include	27
pediatric radiologists	27
study period	27
mycobacterium tuberculosis	27
patient population	27
currently available	27
rheumatoid arthritis	27
polymerase chain	27
use authorization	27
pharmaceutical industry	27
hemolytic transfusion	27
informed consent	27
antiviral activity	27
blood samples	27
brain mri	26
per patient	26
dependent rna	26
one year	26
two different	26
combination therapy	26
information system	26
serologic testing	26
product development	26
university hospital	26
respiratory tract	26
west nile	26
amino acid	26
mean age	26
american society	26
good manufacturing	26
patient samples	26
imaging modalities	26
regulatory agencies	26
physical examination	26
patients treated	26
antibody identification	25
may require	25
iu ml	25
technical requirements	25
allergic reactions	25
molecular testing	25
respiratory syncytial	25
year old	25
guidance documents	25
high titer	25
bact alert	25
diagnostic test	25
medical records	25
blood collection	25
false positive	25
image gently	25
manual cleaning	25
main protease	25
lung cancer	25
host cells	25
high level	25
nile virus	24
significantly increased	24
positive results	24
east respiratory	24
natural products	24
total number	24
new york	24
cord blood	24
pregnant women	24
active site	24
hcv rna	24
years old	24
draft guidance	24
organ transplant	24
recent years	24
pictorial review	24
quality improvement	24
nervous system	24
hospital transfusion	24
transfusion recipients	24
patient harm	24
marrow transplantation	24
type i	23
emerging infectious	23
single market	23
care unit	23
food animals	23
patients undergoing	23
pseudomonas aeruginosa	23
platelet concentrates	23
gastrointestinal endoscopes	23
donor program	23
working groups	23
healthcare professionals	23
protease inhibitors	23
review process	23
quality assurance	23
harmonization initiatives	23
platelet counts	23
breast cancer	23
medical products	23
european pharmaceutical	23
donor center	23
level disinfectants	22
liquid chemical	22
ligand efficiency	22
scientific advice	22
bacterial infections	22
assisted laser	22
pediatric patient	22
best practices	22
burkholderia pseudomallei	22
safety data	22
mri findings	22
laser desorption	22
national blood	22
imaging studies	22
transfusion practice	22
information regarding	22
safety concerns	22
solid organ	22
oocyte donation	22
central nervous	22
units transfused	22
risk factor	22
colorectal cancer	22
task force	22
ill patients	22
age group	22
gene expression	22
fda guidance	22
vitek ms	22
oocyte donors	22
host cell	22
patients received	22
within days	22
drug resistance	22
pandemic influenza	21
see table	21
global health	21
class i	21
desorption ionization	21
mouse model	21
generation sequencing	21
viral infection	21
logistic regression	21
significantly different	21
platelet products	21
us food	21
copies ml	21
antibody screening	21
biological product	21
efficacy data	21
virus disease	21
drug regulatory	21
virtual screening	21
first step	21
flow cytometric	21
infectious agents	21
interstitial lung	21
compounding errors	21
deferral rates	21
investigational new	21
gi endoscopes	21
will continue	21
broad range	21
convalescent plasma	21
frozen plasma	21
patient information	21
global cooperation	21
previously reported	21
also used	21
reference laboratory	21
syncytial virus	21
several years	21
per month	21
several studies	21
clinical presentation	21
based approach	21
time period	21
approved drug	21
clinical microbiology	21
animal studies	21
better understanding	21
simplex virus	20
took place	20
blood system	20
compounding pharmacies	20
transfusion protocol	20
ad hoc	20
federal regulations	20
first time	20
predictive value	20
chronic hepatitis	20
lopinavir ritonavir	20
high throughput	20
influenza virus	20
healthcare system	20
preclinical studies	20
emergency department	20
scd patients	20
serological tests	20
pcr assays	20
mayo clinic	20
producing animals	20
binding affinity	20
health system	20
even though	20
inventory management	20
evaluated using	20
risk management	20
bacterial pathogens	20
approval process	20
respiratory viruses	20
log reduction	20
care facilities	20
educational exhibit	20
results showed	20
centralized procedure	20
medical countermeasures	20
molecular docking	20
therapeutic plasma	20
injection site	20
gastrointestinal endoscopy	20
infected patients	20
myeloid leukemia	20
cell culture	19
new technologies	19
compounding pharmacy	19
also known	19
drug manual	19
five years	19
clinically relevant	19
marrow transplant	19
platelet inventory	19
gold standard	19
blood stem	19
canadian blood	19
control group	19
early diagnosis	19
mutual recognition	19
high levels	19
apheresis platelet	19
cd deficiency	19
concept paper	19
anaphylactic reactions	19
animal species	19
directive eec	19
rhd gene	19
escherichia coli	19
may lead	19
quality medicines	19
potential donors	19
antimicrobial agents	19
statistical analysis	19
cancer drug	19
resistant bacteria	19
trauma patients	19
analyzed using	19
platelet transfusion	19
shelf life	19
regulatory harmonization	19
based products	19
national medical	19
practice guidelines	19
plasma units	19
medical history	18
per day	18
seasonal influenza	18
life cycle	18
turnaround time	18
human disease	18
hemorrhagic fever	18
one study	18
ct imaging	18
last years	18
clinical course	18
animal production	18
may provide	18
confirmatory testing	18
new drugs	18
i ii	18
hydrogen bonds	18
approved cleared	18
molecular diagnostics	18
dtc covid	18
toxicity studies	18
repeat testing	18
antiviral drug	18
rbc transfusions	18
iron deficiency	18
ml kg	18
large number	18
clinical outcomes	18
two groups	18
nonhuman primates	18
platelet units	18
critically ill	18
blood pressure	18
room temperature	18
drug safety	18
human cells	18
exhibit will	18
united kingdom	18
rare donor	18
flight mass	18
clinical evaluation	18
ema assessment	18
risk assessment	18
marrow donor	18
tyrosine kinase	18
also provides	18
samples tested	18
will provide	18
ct scans	18
pathogen inactivation	18
phs act	17
female donors	17
many years	17
global harmonization	17
virus type	17
significant increase	17
clinical symptoms	17
treated rbcs	17
donors may	17
randomized controlled	17
pharmaceutical regulation	17
two patients	17
rejuvenation solution	17
prospective study	17
rhd beadchip	17
age groups	17
high resolution	17
may result	17
may occur	17
compassionate use	17
liver disease	17
endoscope channels	17
clinical significance	17
cosmetic act	17
ethylene glycol	17
viral entry	17
transfusion transmitted	17
manufacturing practice	17
nucleic acids	17
vascular anomalies	17
neutralizing antibodies	17
safety evaluation	17
viral particles	17
blood service	17
genomic dna	17
patient outcomes	17
binding energy	17
screening test	17
pediatric radiologist	17
hospital background	17
factor receptor	17
small number	17
clinical features	17
safety profile	17
animal feed	17
blood transfusions	17
controlled trials	17
new antibiotics	17
blood ordering	17
dna sequencing	17
vitro quality	17
results suggest	16
tube testing	16
molecular methods	16
high prevalence	16
vaccine safety	16
volume reduction	16
business plan	16
image noise	16
federal food	16
cancer cells	16
multiple sclerosis	16
pl pro	16
final product	16
leucocyte depleted	16
severe covid	16
million people	16
manufacturing process	16
donor samples	16
recent studies	16
will require	16
cell types	16
ich process	16
national health	16
genetic material	16
family members	16
health emergencies	16
clinical benefit	16
product labeling	16
risks associated	16
genome project	16
flexible gastrointestinal	16
type ii	16
fresh frozen	16
patient management	16
high frequency	16
small molecules	16
hypersensitivity reactions	16
will review	16
made available	16
lung injury	16
safety studies	16
blood screening	16
statistical significance	16
academic medical	16
study group	16
vast majority	16
clinical efficacy	16
jakob disease	16
real time	16
monoclonal anti	16
donor population	16
renal function	16
manual tube	16
harmonization activities	16
significant impact	16
culture results	16
chest ct	16
antigen expression	16
drug candidates	16
new automated	16
donated blood	16
infusion reactions	16
retrospective analysis	16
decision making	16
negative results	16
clostridium difficile	16
speci fi	16
drug name	16
age range	16
directive ec	15
accelerated approval	15
donor testing	15
drug supply	15
two cases	15
standard deviation	15
wide variety	15
research institute	15
scientific community	15
harmonization initiative	15
transfused patients	15
respiratory virus	15
healthcare facilities	15
dtt treatment	15
nuclear transfer	15
restricted diffusion	15
drug quality	15
vaccine manufacturers	15
genetic variants	15
antiglobulin test	15
treated cells	15
mdct images	15
clinical need	15
hcv infection	15
surgical instruments	15
also developed	15
rbcs stored	15
lymph nodes	15
laboratory tests	15
hemolytic disease	15
reagent red	15
expanded access	15
regional harmonization	15
traditional medicines	15
event reporting	15
developed countries	15
human papillomavirus	15
also performed	15
interventional radiology	15
francisella tularensis	15
dose reduction	15
rhd diiia	15
ferritin levels	15
iron metabolism	15
negative blood	15
international organizations	15
weighted imaging	15
additive solution	15
end point	15
terumo bct	15
performance characteristics	15
chest pain	15
community hospitals	15
important step	15
study conducted	15
amotosalen uva	15
human monoclonal	15
respiratory distress	15
chest wall	15
european commission	15
cohort study	15
stored rbcs	15
cd cell	15
care providers	15
health history	15
virus infections	15
income countries	15
emergency release	15
influenza vaccines	15
treatment options	15
care professionals	15
acute myeloid	15
european community	15
years ago	15
will help	15
become available	15
rbc unit	15
hydrophobic interactions	15
therapy products	15
blood flow	15
voluntary blood	15
fast track	15
male donors	15
controlled trial	15
low dose	15
regulatory pathways	15
molecular pathology	15
virus replication	15
white blood	15
irb approval	15
antibody therapy	14
significant antibodies	14
trauma center	14
inhibitory activity	14
reference materials	14
crystal structure	14
improve patient	14
pathogen reduced	14
mg kg	14
eu member	14
recombinant dna	14
cell lung	14
clinical outcome	14
fda regulations	14
human clinical	14
investigational drugs	14
hbv dna	14
negative rbcs	14
accurate diagnosis	14
imaging characteristics	14
solid phase	14
corpus callosum	14
standard tube	14
median age	14
duke university	14
management system	14
diagnostic accuracy	14
neg rbc	14
high degree	14
antibody screens	14
drug use	14
potential risks	14
university school	14
medicines regulatory	14
angiotensin receptor	14
serious adverse	14
potential inhibitors	14
three years	14
direct antiglobulin	14
national regulatory	14
broad spectrum	14
comparator assay	14
current good	14
allogeneic blood	14
imaging techniques	14
nf patients	14
tissue factor	14
readily available	14
false negative	14
therapeutic options	14
many countries	14
accidental trauma	14
pictorial essay	14
present study	14
pharmaceutical system	14
radiation exposure	14
may help	14
old male	14
tube method	14
hemoglobin levels	14
room decontamination	14
developed tests	14
infections associated	14
information leaflet	14
immune globulin	14
blood banking	14
efficacy studies	14
therapeutic use	14
growth promotion	14
regulatory framework	14
rbc products	14
structural proteins	14
fda also	14
cell line	14
rna viruses	14
young children	14
blood systems	14
safety issues	14
fda drug	14
will need	14
portal vein	14
measured using	14
donor evaluation	14
cell substrates	14
cost savings	14
natural history	14
large volume	14
potential benefits	14
donate blood	14
imaging appearances	13
transfusion testing	13
will likely	13
adenoviral vector	13
psoriatic arthritis	13
accessed april	13
institutional review	13
data collected	13
compounded medications	13
critical role	13
new vaccines	13
standard operating	13
patient age	13
dtc tests	13
priority review	13
retrospectively reviewed	13
factor viii	13
rh typing	13
vaccine candidate	13
ex vivo	13
sterile drug	13
cancer therapy	13
enzyme inhibitors	13
clinical study	13
buffy coat	13
ionizing radiation	13
creative commons	13
based blood	13
human mab	13
clinical utility	13
single unit	13
testing using	13
healthcare providers	13
private sector	13
animal agriculture	13
patients requiring	13
old female	13
resistant enterobacteriaceae	13
one unit	13
heart failure	13
bacterial spores	13
four patients	13
average number	13
hepatocellular carcinoma	13
european parliament	13
often used	13
recent study	13
child abuse	13
respiratory infections	13
food animal	13
blood pool	13
hematopoietic cell	13
likely due	13
well tolerated	13
literature review	13
international cooperation	13
binding pocket	13
automated endoscope	13
sample collection	13
reprocessing personnel	13
postmarketing studies	13
clinical evidence	13
neutralizing antibody	13
surface area	13
cell surface	13
ductus arteriosus	13
irradiated blood	13
low ferritin	13
pediatric spine	13
national institute	13
breast milk	13
hla antibodies	13
storage lesion	13
many cases	13
harmonization process	13
cell transplant	13
results indicate	13
transfusion safety	13
lessons learned	13
hiv viral	13
plasma samples	13
donor eligibility	13
emergency blood	13
patients without	13
quantitative pcr	13
confirmed positive	13
therapeutic agents	13
genotyping results	13
additional studies	13
fda issued	13
regression analysis	13
studies may	13
blood supplier	13
highly conserved	13
also important	13
adverse effect	13
zikv rna	13
rhd genotyping	13
body weight	12
negative bacteria	12
retrograde cholangiopancreatography	12
falsified medicines	12
predicted phenotype	12
two years	12
cell therapy	12
cell death	12
humanized mab	12
global public	12
antigen negative	12
multiple myeloma	12
lead molecules	12
response rate	12
immature platelet	12
laboratory developed	12
european countries	12
technical document	12
thawed plasma	12
prostate cancer	12
regulatory issues	12
correctly identified	12
contrast agent	12
release syndrome	12
fi cation	12
based transfusion	12
chart review	12
imaging modality	12
treat covid	12
antiviral agents	12
rapid diagnosis	12
host immune	12
pharmaceutical sector	12
per unit	12
kidney transplant	12
reporting system	12
patients infected	12
observational study	12
antibody testing	12
diagnostic imaging	12
may vary	12
drug approval	12
false positives	12
gestational age	12
linear regression	12
reusable medical	12
normal controls	12
optic nerve	12
data management	12
dengue virus	12
imaging appearance	12
patient access	12
serum albumin	12
higher risk	12
us blood	12
pharmaceutical market	12
urinary tract	12
marketing application	12
pharmaceutical product	12
currently used	12
apheresis donors	12
viral levels	12
outsourcing facility	12
also allows	12
studies using	12
hours post	12
pcr assay	12
gene sequencing	12
saudi arabia	12
days post	12
replacement fluid	12
vitro studies	12
highly sensitive	12
limited number	12
reference standard	12
may affect	12
human plasma	12
human serum	12
health service	12
reactive samples	12
converting enzyme	12
casi systems	12
microbial contamination	12
within weeks	12
high sensitivity	12
three regions	12
flexible endoscope	12
biofilm formation	12
testicular torsion	12
committee meeting	12
tract infections	12
clinical findings	12
growth factors	12
tumor cells	12
regulatory systems	12
effective dose	12
tested using	12
rna dependent	12
amino acids	12
security act	12
binding site	12
inclusion criteria	12
ovarian cancer	12
virus entry	12
hospital blood	12
manufacturing methods	12
next generation	12
alloimmunized patients	12
nat yield	12
aasld idsa	12
less common	12
ethylene oxide	12
group system	12
previous studies	12
patient size	12
single dose	12
liquid chromatography	12
one week	12
rhd weak	12
cytokine release	12
gently campaign	12
regulatory oversight	12
high incidence	12
cervical spine	12
cardiovascular disease	12
time quantitative	12
dtc health	12
cell collection	12
rhd negative	12
receptor blockers	12
methods used	12
manufacturing practices	11
fast brain	11
must also	11
casi system	11
derived pharmaceuticals	11
hod otii	11
treated patients	11
split rate	11
first case	11
prenatal ultrasound	11
surgical management	11
united nations	11
ii clinical	11
peracetic acid	11
vein thrombosis	11
infantile hemangiomas	11
compatible blood	11
umbilical cord	11
hospital medical	11
low titer	11
hematology analyzer	11
transfusion committee	11
dpg levels	11
also evaluated	11
drug shortages	11
will certainly	11
african american	11
many patients	11
technician related	11
antigen typing	11
therapeutic intervention	11
irb approved	11
bacillus anthracis	11
rapid detection	11
african americans	11
also available	11
three patients	11
endoscopic retrograde	11
associated virus	11
procedures performed	11
phone calls	11
plasma replacement	11
high dose	11
staff time	11
cell migration	11
congenital anomalies	11
two decades	11
also reported	11
cell proliferation	11
screening tests	11
five patients	11
accessed dec	11
six months	11
donor history	11
nip rhd	11
lower extremity	11
reprocessing guidelines	11
less frequently	11
disease transmission	11
fever virus	11
potential therapeutic	11
ab plasma	11
diabetes mellitus	11
among blood	11
hla typing	11
based assay	11
hiv aids	11
hb deferral	11
physical exam	11
dtc testing	11
rhesus monkeys	11
testing may	11
plt count	11
resistant staphylococcus	11
patient identification	11
reactions occurred	11
cxcr pd	11
international harmonization	11
valid act	11
significantly reduced	11
microsatellite instability	11
post thaw	11
molecular weight	11
iii trial	11
individual patients	11
routine use	11
patient received	11
surface antigen	11
intellectual property	11
lower risk	11
case examples	11
essential medicines	11
repurposing approach	11
mr images	11
aortic arch	11
peptide vaccine	11
protease inhibitor	11
good quality	11
common technical	11
cells ml	11
drug substances	11
clinical disease	11
regulatory network	11
influenza vaccine	11
cell units	11
herbal medicines	11
commonly encountered	11
clinical manifestations	11
key role	11
abo typing	11
viral culture	11
cell processor	11
low levels	11
results show	11
pivotal role	11
clinical diagnostics	11
cd tregs	11
will focus	11
liver transplantation	11
vertebral fractures	11
regulatory convergence	11
patient width	11
successfully treated	11
causative agent	11
automated bp	11
phase clinical	11
clinical information	11
platelet transfusions	11
transfusion transmission	11
technical cooperation	11
international collaboration	11
organ transplantation	11
clinical setting	11
pediatric musculoskeletal	11
laboratory data	11
national level	11
cotton rats	11
issues related	11
titer anti	11
treatment response	11
biothreat pathogens	11
donor plasma	11
tranexamic acid	11
among patients	11
automated alinity	11
study shows	11
skeletal surveys	11
quality standards	11
acid amplification	11
iron depletion	11
blood specimens	11
epidermal growth	11
htlv i	11
clinical characteristics	11
fungal infections	11
viral pathogens	11
regional office	11
university medical	11
national institutes	11
antimicrobial drugs	11
iron levels	11
disease prevention	11
buffy coats	11
prescription drug	11
small bowel	11
window period	11
data set	11
birth weight	11
renal failure	11
participants receiving	11
serological testing	10
drug reactions	10
single donor	10
innate immune	10
data collection	10
therapeutic targets	10
clinical needs	10
timely manner	10
patent ductus	10
current study	10
adjuvanted vaccine	10
cross blood	10
level i	10
von willebrand	10
neonatal intensive	10
probe prodesse	10
significant role	10
exposure time	10
stored rbc	10
temporal resolution	10
nucleotide sequence	10
relatively low	10
yersinia pestis	10
pulmonary fibrosis	10
fatty infiltration	10
platelet additive	10
acute lung	10
mucous membranes	10
rib fractures	10
ttp patients	10
similar results	10
technical guidelines	10
process improvement	10
small cell	10
abo bw	10
laboratory information	10
additional information	10
serum sickness	10
american association	10
abdominal pain	10
positive antibody	10
economic integration	10
appropriate use	10
row ct	10
positive impact	10
recent fda	10
acid testing	10
nat screening	10
donor unit	10
imaging plays	10
effective use	10
way valve	10
blood count	10
rbc storage	10
titer results	10
new zealand	10
routinely used	10
clinical management	10
ct angiography	10
product wastage	10
donor care	10
operating procedures	10
preliminary data	10
species level	10
pharmacy compounding	10
ovarian reserve	10
zkv testing	10
one case	10
level disinfectant	10
wbc count	10
donor health	10
days prior	10
ethics committee	10
disease patients	10
low cost	10
mri studies	10
virulence factors	10
set forth	10
samples obtained	10
analysis showed	10
dna sequence	10
cell count	10
ap donors	10
related issues	10
clinical research	10
genetically modified	10
large numbers	10
crossmatch compatible	10
certain types	10
apheresis procedures	10
bacterial culture	10
added value	10
guidance document	10
myelogenous leukemia	10
biothreat agents	10
voluntary recall	10
review board	10
developed procedures	10
significant reduction	10
cell lymphoma	10
coronary artery	10
data suggest	10
license application	10
first line	10
endoscope reprocessors	10
venous thrombosis	10
papilloma virus	10
brain tumor	10
regulatory approval	10
working party	10
analytical sensitivity	10
spectra optia	10
hla class	10
human anti	10
eosinophilic asthma	10
patients showed	10
widespread use	10
adenoviral vectors	10
also showed	10
development process	10
away time	10
protein kinase	10
genetically engineered	10
information sharing	10
test result	10
immunohematology reference	10
significant decrease	10
blood groups	10
us billion	10
american pathologists	10
common market	10
previously described	10
baseline viral	10
pediatric imaging	10
cd cd	10
mab used	10
clinical care	10
clinical applications	10
effective treatment	10
new process	10
storage period	10
rbc alloantibodies	10
smallpox vaccine	10
rhd xt	10
cmv disease	10
pcr tests	10
rapid identification	10
critical care	10
bilateral cooperation	10
per million	10
tract infection	10
drug evaluation	10
fda alerts	10
study population	10
airway compression	10
also established	10
bowel obstruction	10
management board	10
dna samples	10
routine clinical	10
neck masses	10
family history	10
food drug	10
chronically transfused	10
long term	10
prevent unnecessary	10
serologic weak	10
success rate	10
result verification	10
heart rate	10
patients may	10
adenovirus vectors	10
renal transplantation	10
work together	10
hospitalized patients	10
drug product	10
post collection	10
making process	10
pharmaceutical domain	10
new classification	10
staff training	10
international standard	10
different stages	10
baby units	10
clinical samples	10
medicine background	10
kinase inhibitor	10
safety communication	10
competent authorities	10
high quality	10
confidence interval	10
difficile spores	10
final concentration	10
relatively high	10
disease testing	10
motion artifacts	10
pharmaceutical compounding	10
peg iat	10
chemical sterilants	10
study aimed	10
pediatric brain	10
human papilloma	10
fresenius kabi	10
matched controls	10
sexually transmitted	10
anaphylactic reaction	10
antiretroviral therapy	10
pathogenic mutations	10
packed red	10
major concern	10
may cause	10
donor deferrals	10
brain injury	10
regulatory system	10
final rule	10
without compromising	10
pediatric ct	10
different types	10
laboratory medicine	10
laboratory results	10
rbc alloimmunization	10
drug companies	10
economic growth	10
european system	10
life sciences	10
nat testing	10
country offices	10
platelet recovery	10
veterinary medicine	10
cells kg	10
sterile tissue	10
id rhd	10
modernization act	10
general population	10
fold increase	10
label use	10
platelet adhesion	10
urgent need	10
epidermolysis bullosa	10
culture bottles	9
quality management	9
health assembly	9
cancer institute	9
protein structures	9
pcr technology	9
hospitalized covid	9
related donor	9
safety pharmacology	9
routine quality	9
study will	9
distress syndrome	9
north america	9
quality drugs	9
recently published	9
findings suggest	9
pdb id	9
adverse reaction	9
healthy donors	9
ongoing clinical	9
screening assay	9
central venous	9
physical evidence	9
spongiform encephalopathy	9
randomized clinical	9
quality systems	9
human efficacy	9
patients developed	9
vaccine industry	9
postnatal imaging	9
high specificity	9
volume processed	9
pfu ml	9
take place	9
rbc antigens	9
ankylosing spondylitis	9
animal efficacy	9
leading cause	9
data sets	9
poster will	9
adult patients	9
indirect antiglobulin	9
ionization time	9
cd expression	9
drug resistant	9
reduction technology	9
important antibiotics	9
multiplex pcr	9
bacterial infection	9
inventory levels	9
egg donors	9
different countries	9
toxic effects	9
post transfusion	9
mental health	9
time donors	9
mortality rate	9
animal drug	9
compounding error	9
imaging centers	9
end points	9
fda label	9
also found	9
federal agencies	9
derived products	9
cov cl	9
clinic background	9
approved tests	9
package insert	9
appropriate management	9
cerebrospinal fluid	9
laboratory operations	9
use sterile	9
well documented	9
dif fi	9
drug used	9
molecule inhibitors	9
data base	9
bloodstream infections	9
liquid plasma	9
pharmacology studies	9
ich guidance	9
abdominal ct	9
viral protein	9
hiv rna	9
closed system	9
retrospective cohort	9
tissue masses	9
general hospital	9
conventional mri	9
brand name	9
good clinical	9
interested parties	9
mr urography	9
plasma volume	9
complications associated	9
vaccine market	9
drugs used	9
trima accel	9
blood cultures	9
preclinical animal	9
third party	9
transfusion practices	9
testing process	9
study published	9
gi endoscopy	9
economic development	9
brain barrier	9
million doses	9
blood culture	9
will allow	9
medicinal product	9
process development	9
tested positive	9
will facilitate	9
recent developments	9
among others	9
pediatric age	9
septic transfusion	9
mean number	9
san diego	9
safe blood	9
transplant patients	9
new information	9
metastatic colorectal	9
patients affected	9
adc values	9
analysis revealed	9
blood order	9
signal intensity	9
administrative simplification	9
data needed	9
rhce cehar	9
resistant enterococci	9
important tool	9
challenge studies	9
spike protein	9
safety reports	9
health information	9
targeted therapy	9
pilot projects	9
free trade	9
pilot study	9
done using	9
test methods	9
one additional	9
human coronavirus	9
care testing	9
nasopharyngeal swab	9
future studies	9
reprocessing flexible	9
viral target	9
puerto rico	9
clinical testing	9
vaccine injury	9
vaccine supply	9
health policy	9
failed runs	9
therapeutic decision	9
mitigation strategies	9
reverse transcription	9
preclinical safety	9
various types	9
antibody formation	9
associated pathogens	9
hla antibody	9
ct radiation	9
findings included	9
national marrow	9
chemical sterilant	9
stability studies	9
product quality	9
international conference	9
stimulating factor	9
teg results	9
positive donations	9
major public	9
platelet components	9
poor quality	9
target cells	9
atopic dermatitis	9
severe reactions	9
staff review	9
molecular biology	9
contrast enhanced	9
strategic plan	9
national cancer	9
significance measure	9
receiving mg	9
rbc exchange	9
using high	9
extremely rare	9
typing results	9
high cost	9
active pharmaceutical	9
rhd variant	9
patients presented	9
care settings	9
competing interests	9
cerus corporation	9
liver transplant	9
laboratory improvement	9
significantly decreased	9
normal anatomy	9
developing new	9
therapeutic agent	9
binding energies	9
months post	9
approximately million	9
cytomegalovirus disease	9
reprocessing area	9
based guidelines	9
member economies	9
delayed hemolytic	9
allogeneic donors	9
pediatric spinal	9
phase red	9
viral dna	9
immucor neo	9
vaccine development	9
osteoid osteomas	9
medical treatment	9
side effect	9
published literature	9
sense rna	9
two additional	9
nk cell	9
tandem mass	9
diagnostic quality	9
healthy controls	9
odds ratio	9
may become	9
confidentiality agreements	9
medical director	9
back pain	9
performed within	9
donor recruitment	9
free movement	9
potential drug	9
yellow fever	9
will become	9
inflammatory response	9
health professionals	9
total blood	9
radiology residents	9
surgical blood	9
willebrand factor	9
studies suggest	9
skin rash	9
using molecular	9
platelet collections	9
tyrosinase inhibitors	9
help identify	9
fda safety	9
biologics control	9
production practices	9
adverse drug	9
common features	9
clone anti	9
viral vaccines	9
human challenge	9
comprehensive review	9
plasma wastage	9
proinflammatory cytokines	9
ortho clinical	9
approved assays	9
normal saline	9
day post	9
information exchange	9
eu countries	9
identify new	9
current guidelines	9
test scores	9
brain tumors	9
clinical suspicion	9
adverse outcomes	9
acute scrotum	9
positive dat	9
femoral head	9
pharmaceutical supply	9
also tested	9
retinoic acid	9
autoimmune hemolytic	9
quantitative method	9
potential targets	9
randomly selected	9
using two	9
anchor suture	9
will illustrate	9
important antimicrobials	9
significantly reduce	9
laboratories must	9
vascular malformations	9
acid test	9
integration process	8
cytokine storm	8
complete blood	8
liver damage	8
various imaging	8
term safety	8
consensus guidelines	8
time rt	8
musculoskeletal disorders	8
variant creutzfeldt	8
multiple patients	8
counterfeit medicines	8
already known	8
medical care	8
also reviewed	8
will remain	8
next step	8
health departments	8
services background	8
trypanosoma cruzi	8
donor oocyte	8
weeks gestation	8
assays using	8
pathogenic bacteria	8
cell adherence	8
cobe spectra	8
data analysis	8
new system	8
health ministers	8
yet another	8
drug interactions	8
rh phenotype	8
drug manufacturers	8
retention anchor	8
temporal bone	8
neurofibromatosis type	8
molecular assays	8
roche cobas	8
rh blood	8
group antigens	8
available data	8
management systems	8
international pharmacopoeia	8
first two	8
special emphasis	8
south africa	8
mononuclear cells	8
phase iv	8
first years	8
thrombin generation	8
partial plasma	8
medical conditions	8
three days	8
ich secretariat	8
drug design	8
technical assistance	8
total bilirubin	8
wastage rates	8
fully automated	8
oneg patients	8
fat suppression	8
four different	8
evidence based	8
chronic hcv	8
collection process	8
cytometric method	8
renovascular hypertension	8
respiratory failure	8
infectious titer	8
hla matched	8
commonly reported	8
may impact	8
somatic cell	8
spectrum antiviral	8
european economic	8
best practice	8
became evident	8
technologist time	8
least two	8
human subjects	8
amplicor mycobacterium	8
medical school	8
well understood	8
serious risk	8
rare donors	8
screened drugs	8
first months	8
gram stain	8
hiv infection	8
thrombotic thrombocytopenic	8
market withdrawals	8
repurposed drugs	8
alloimmunization rates	8
technical staff	8
body fluids	8
new legislation	8
study investigated	8
exchange information	8
transfusion hemoglobin	8
cancer center	8
igm positive	8
pediatric hospital	8
intestinal obstruction	8
sample size	8
spinal canal	8
nerve hypoplasia	8
included patients	8
identify patients	8
lymphoblastic leukemia	8
antibiotics used	8
history questionnaire	8
health threats	8
three ich	8
back projection	8
infection prevention	8
weeks among	8
south korea	8
individual countries	8
true positive	8
antibody response	8
genome sequencing	8
medical practice	8
gradient echo	8
rbc samples	8
current state	8
coagulation factor	8
health risks	8
barr virus	8
cell donors	8
among men	8
whenever possible	8
lassa virus	8
chronic myeloid	8
platelet usage	8
viral genomes	8
pe group	8
two distinct	8
disease indications	8
host disease	8
molecule antiviral	8
positive cultures	8
plain film	8
vary depending	8
give blood	8
cranial nerve	8
two days	8
studies performed	8
total body	8
iron supplementation	8
human cd	8
pediatric stroke	8
health issues	8
federal register	8
cell antibodies	8
cmnc protocol	8
pediatric abdominal	8
three different	8
pulmonary arteries	8
many areas	8
coxiella burnetii	8
sample types	8
protein synthesis	8
regulatory agency	8
screened molecules	8
molecular mechanisms	8
autoimmune diseases	8
annual report	8
inflammatory bowel	8
group ab	8
study demonstrates	8
different blood	8
may contribute	8
cotton rat	8
influenza viruses	8
raised without	8
implementation period	8
tubal torsion	8
antibiotic treatment	8
lupus erythematosus	8
oneg rbcs	8
controlled clinical	8
human igg	8
bulk drug	8
initial presentation	8
angiotensin ii	8
data may	8
microbiologic surveillance	8
single chain	8
molecular basis	8
product utilization	8
week period	8
screening assays	8
recommended vaccines	8
crystal structures	8
considered significant	8
vaccine formulation	8
apheresis collection	8
chronic myelogenous	8
venous flow	8
cell transfusion	8
tpe procedures	8
health resources	8
sample preparation	8
life threatening	8
ct findings	8
patient populations	8
swab samples	8
two samples	8
pediatric elbow	8
immediate spin	8
assessed using	8
will include	8
clinical safety	8
paediatric patients	8
collaborating centers	8
contact time	8
simulated transfusion	8
term follow	8
improvement amendments	8
hospital system	8
raw materials	8
pharmaceutical ingredients	8
literature search	8
ortho vision	8
compounded drug	8
table shows	8
potential risk	8
muscle mass	8
van der	8
better understand	8
following transfusion	8
regulatory standards	8
first week	8
emergency units	8
testing must	8
scientific consensus	8
environmental contamination	8
protein interaction	8
study evaluated	8
oxygen saturation	8
second sample	8
gel card	8
vero cells	8
environmental surfaces	8
human volunteers	8
based methods	8
significant change	8
peroxisomal disorders	8
may need	8
triglyceride levels	8
comparative studies	8
noncritical items	8
regulatory information	8
increasing number	8
system using	8
also identified	8
suspected non	8
drug report	8
among countries	8
fda review	8
health insurance	8
crucial role	8
time frame	8
cleared naats	8
severe reaction	8
wide spectrum	8
integration model	8
laboratory practice	8
case reports	8
tortuosity syndrome	8
acute lymphoblastic	8
fibrinogen levels	8
key residues	8
reference laboratories	8
virus vectors	8
mouse models	8
fusion protein	8
collection procedures	8
expression levels	8
contamination errors	8
platelet clearance	8
significantly associated	8
transfusion related	8
diagnostics regulation	8
reprocessing instructions	8
healthy individuals	8
pak lx	8
near future	8
dna testing	8
gmp inspections	8
product safety	8
administration fda	8
hearing loss	8
blood derived	8
emergently issued	8
naturally occurring	8
potential impact	8
safety study	8
storage duration	8
consecutive patients	8
us army	8
automated gel	8
specific topics	8
concentration errors	8
critical information	8
cingulate gyrus	8
two weeks	8
concerns regarding	8
without antibiotics	8
one month	8
hgb hct	8
orp values	8
toxicology studies	8
progenitor cell	8
treatment strategies	8
treatment duration	8
mp content	8
result reporting	8
quality system	8
storage conditions	8
ich parties	8
identify compounds	8
ligamentous injury	8
related reactions	8
prbc units	8
widely available	8
significant changes	8
immune cells	8
new method	8
ich gcg	8
vitro diagnostic	8
mesenchymal stem	8
efflux pump	8
thrombocytopenic purpura	8
organ transplants	8
clinical relevance	8
assess whether	8
functional connectivity	8
harmonized standards	8
skeletal survey	8
blood utilization	8
early stages	8
host factors	8
may offer	8
resistance mechanisms	8
covalent interactions	8
significantly greater	8
gastroenterology nurses	8
study demonstrated	8
single patient	8
two types	8
primary care	8
mpr mdct	8
negative samples	8
filtered back	8
legal framework	8
published guidelines	8
bpn bottles	8
community blood	8
electronic system	8
system will	8
irradiated rbcs	8
may present	8
history screening	8
ir include	8
emergent situations	8
immunodeficiency syndrome	8
internal market	8
luminex bead	8
mechanical ventilation	8
member countries	8
th percentile	8
plt units	8
high volume	8
working parties	8
arterial tortuosity	8
cross sectional	8
matched units	8
small sample	8
procedure cd	8
based assays	8
hematological parameters	8
related complications	8
vegetative bacteria	8
like protease	8
semicritical items	8
contrast agents	8
klebsiella pneumoniae	8
kinase inhibitors	8
large scale	8
sanger sequencing	8
platelet refractoriness	8
skeletal dysplasias	8
facilitated regulatory	8
products derived	8
factors associated	8
tuberculosis complex	8
platelet yield	8
discovery studio	8
identified using	8
matched platelets	8
plasmodium falciparum	8
rhd alleles	8
ferritin testing	8
protein targets	8
regulatory compliance	8
ivd device	8
part i	8
tomography images	8
studies will	8
upload time	8
disease caused	8
abo blood	8
higher incidence	8
new therapeutics	8
universal screening	8
elevator channel	8
receptor binding	8
multimodality imaging	8
characteristic imaging	8
two major	8
automated solid	8
ii iii	8
negative antibody	8
action plan	8
appointment booking	8
internal control	8
integral part	8
blood sample	8
sick children	8
backbone nitrogen	7
hcv treatment	7
molecular genotyping	7
whole genome	7
management plan	7
transport media	7
new medicines	7
samples using	7
content imaging	7
way anova	7
log pfu	7
wilms tumor	7
bacterial growth	7
including patient	7
ich website	7
different regions	7
weeks post	7
guidelines recommend	7
post processing	7
using standard	7
cell antigens	7
repurposing study	7
help improve	7
jane bryant	7
operations demand	7
babesia microti	7
gregg williams	7
screening methods	7
upper respiratory	7
war ii	7
clinical performance	7
ct group	7
study using	7
prediction algorithm	7
new technology	7
infusion reaction	7
may prevent	7
arachidonic acid	7
progressive disease	7
cell concentrates	7
microbiology laboratory	7
transfusion therapy	7
significantly improved	7
regulatory affairs	7
pharmaceutical legislation	7
low doses	7
reduced risk	7
abnormal risk	7
processing system	7
implementation plan	7
remote blood	7
significant correlation	7
specific products	7
supplemental table	7
industry associations	7
share information	7
communicable disease	7
patients whose	7
analysis using	7
bovine spongiform	7
emptive therapy	7
maximum surgical	7
plaque psoriasis	7
using autodock	7
first infusion	7
transfusion guidelines	7
current methods	7
enveloped viruses	7
patients experienced	7
licensed vaccines	7
dose estimates	7
antigen positive	7
contrast images	7
low level	7
sterilization guidelines	7
much lower	7
time since	7
quantitative viral	7
greater risk	7
panel cells	7
commodity waste	7
hemorrhagic shock	7
three categories	7
plasma therapy	7
supply chains	7
food products	7
blood bags	7
unit transfusion	7
cell membrane	7
i clinical	7
clinical staff	7
sars coronavirus	7
potential treatment	7
drug repositioning	7
transfusion protocols	7
massively parallel	7
biological processes	7
strong binding	7
point scale	7
reverse transcriptase	7
less likely	7
ventricular size	7
regulatory process	7
risk behaviors	7
acquired immunodeficiency	7
development programs	7
orphan medicinal	7
vaccine research	7
health laboratory	7
cooperation group	7
fda requires	7
reactive antibodies	7
developing world	7
blood fridge	7
egg donation	7
san francisco	7
regulatory challenges	7
single institution	7
surgical planning	7
use antibiotics	7
st century	7
especially important	7
factor ix	7
marketing authorisation	7
zimmer biomet	7
nuclear medicine	7
iron stores	7
index donations	7
surveillance cultures	7
septic patients	7
services administration	7
throughput screening	7
rabbit model	7
plain radiographs	7
worldwide basis	7
anatomic pathology	7
mm hg	7
study reported	7
genome sequence	7
qt prolongation	7
myocardial infarction	7
pediatric study	7
future state	7
xtag rvp	7
abused children	7
adamts activity	7
operator touchpoints	7
originally developed	7
mg day	7
medical condition	7
economic incentives	7
proficiency testing	7
viral hepatitis	7
ulcerative colitis	7
acid residues	7
murine leukemia	7
executive board	7
laboratory findings	7
rare case	7
scientific assessment	7
lesions include	7
therapeutic effect	7
two agencies	7
five days	7
respiratory disease	7
survival rates	7
gluteus maximus	7
collection facility	7
tests will	7
hospital mortality	7
pcr amplification	7
root causes	7
malaria parasite	7
coronavirus main	7
oxygen affinity	7
therapeutic potential	7
viral targets	7
global regulatory	7
cd yield	7
livestock production	7
sectional imaging	7
target population	7
detailed information	7
children aged	7
resistant gram	7
reference material	7
drug label	7
related failed	7
identi fi	7
treating covid	7
subject matter	7
alerts health	7
molecular tests	7
three main	7
transgenic animal	7
tubing segments	7
increased walk	7
secondary metabolites	7
automatic appointment	7
early stage	7
food supply	7
variant alleles	7
individual patient	7
product characteristics	7
gmp inspection	7
coagulation parameters	7
disease progression	7
cell carcinoma	7
tested negative	7
data elements	7
acute appendicitis	7
medical countermeasure	7
significantly less	7
cell entry	7
hydrogen bond	7
new diagnostics	7
clinical team	7
topics related	7
chagas disease	7
generated using	7
time per	7
icu patients	7
three months	7
hydrogen atoms	7
highly specific	7
product release	7
trials directive	7
plasma transfusion	7
growing number	7
companies may	7
two main	7
antitumor activity	7
site pain	7
ich guideline	7
systemic lupus	7
dose levels	7
also noted	7
academic centers	7
relevant clinical	7
annual meeting	7
genetic variation	7
products collected	7
world war	7
null phenotype	7
brief discussion	7
allogeneic hematopoietic	7
group antigen	7
short term	7
high inhibitor	7
transfused per	7
current status	7
ct scan	7
medicinal chemistry	7
dna chips	7
particularly important	7
rna levels	7
slightly lower	7
statistically different	7
eastern mediterranean	7
infantile hemangioma	7
testing procedures	7